Media stories about Express Scripts Holding (NASDAQ:ESRX) have trended somewhat positive on Monday, according to Accern Sentiment Analysis. The research firm identifies negative and positive news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Express Scripts Holding earned a media sentiment score of 0.12 on Accern’s scale. Accern also gave media headlines about the company an impact score of 68 out of 100, indicating that recent news coverage is likely to have an impact on the company’s share price in the near term.
These are some of the media headlines that may have impacted Accern Sentiment’s rankings:
- Is the Needle Ready to Move on Express Scripts Holding Company (NASDAQ:ESRX)? – FLBC News (flbcnews.com)
- Short Interest in Express Scripts Holding Company (NASDAQ:ESRX) Drops By 10.5% (americanbankingnews.com)
- Express Scripts Holding Company (NasdaqGS:ESRX) Earnings & Valuation in Perspective – Ward Review (wardnewsreview.com)
- Express Scripts Holding Company (NASDAQ:ESRX) Stocks Unloaded By Meag Munich Ergo … – Insider Tradings (insidertradings.org)
- Express Scripts Holding Company (ESRX) stock has a mean analyst rating of 2.70 – Stocks Gallery (stocksgallery.com)
Express Scripts Holding (NASDAQ:ESRX) traded up 1.09% during midday trading on Monday, hitting $62.82. 1,101,356 shares of the company traded hands. The stock’s 50-day moving average is $61.70 and its 200-day moving average is $66.20. The firm has a market capitalization of $37.29 billion, a PE ratio of 11.39 and a beta of 0.90. Express Scripts Holding has a 12-month low of $57.80 and a 12-month high of $79.94.
Express Scripts Holding (NASDAQ:ESRX) last released its earnings results on Monday, April 24th. The company reported $1.33 earnings per share for the quarter, beating analysts’ consensus estimates of $1.32 by $0.01. The business had revenue of $24.65 billion during the quarter, compared to the consensus estimate of $24.95 billion. Express Scripts Holding had a net margin of 3.42% and a return on equity of 25.64%. The firm’s revenue for the quarter was down .6% compared to the same quarter last year. During the same quarter last year, the firm earned $1.22 earnings per share. Analysts anticipate that Express Scripts Holding will post $6.97 EPS for the current fiscal year.
ESRX has been the topic of several research reports. Argus reaffirmed a “hold” rating on shares of Express Scripts Holding in a report on Wednesday, March 29th. Cowen and Company reaffirmed an “outperform” rating and issued a $90.00 price target on shares of Express Scripts Holding in a report on Tuesday, April 4th. Jefferies Group LLC set a $88.00 price target on Express Scripts Holding and gave the company a “buy” rating in a report on Thursday, April 20th. Mizuho dropped their price target on Express Scripts Holding from $76.00 to $61.00 and set a “neutral” rating on the stock in a report on Tuesday, April 25th. Finally, Bank of America Corporation reaffirmed a “neutral” rating and issued a $77.00 price target on shares of Express Scripts Holding in a report on Tuesday, April 25th. Four analysts have rated the stock with a sell rating, twelve have assigned a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $71.89.
COPYRIGHT VIOLATION WARNING: “Express Scripts Holding (NASDAQ:ESRX) Receives Daily Media Impact Rating of 0.12” was originally published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this news story on another domain, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright law. The original version of this news story can be read at https://www.tickerreport.com/banking-finance/2722895/express-scripts-holding-nasdaqesrx-receives-daily-media-impact-rating-of-0-12.html.
In other news, VP Phyllis S. Anderson sold 1,100 shares of Express Scripts Holding stock in a transaction dated Friday, May 19th. The shares were sold at an average price of $60.08, for a total value of $66,088.00. Following the completion of the transaction, the vice president now owns 11,108 shares of the company’s stock, valued at approximately $667,368.64. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Company insiders own 0.68% of the company’s stock.
About Express Scripts Holding
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.